tiprankstipranks
Trending News
More News >
Brainstorm Cell Therapeutics (BCLI)
NASDAQ:BCLI
US Market

Brainstorm Cell Therapeutics (BCLI) Stock Investors

Compare
562 Followers
Based on 803,590 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold BCLI
On average, investors allocate 0.00% of their portfolios to BCLI
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 803,590 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding BCLI

4.0%
Last 7
Days
10.9%
Last 30
Days
Percentages indicate the change in the number of portfolios holding BCLI, out of 803,590 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

BCLI Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
1.04%
$1.60
Based on the activity of investors who made their portfolios public
The table shows changes in BCLI in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

BCLI Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
3.73%
-1.13%
-3.47%
3.25B
Healthcare
DraftKings
4.31%
+2.13%
+4.13%
33.40B
Consumer Cyclical
Nio
7.93%
-0.65%
-2.70%
7.83B
Consumer Cyclical
Lucid Group
5.17%
-0.35%
+0.31%
6.65B
Consumer Cyclical
Marathon Digital Holdings
4.92%
-0.33%
-2.05%
5.75B
Financial
Bristol Myers
3.14%
+0.08%
-1.18%
101.69B
Healthcare
JD
4.51%
-0.84%
-0.59%
53.66B
Consumer Cyclical
Riot Platforms
4.61%
-0.14%
-1.39%
3.77B
Financial
Ford Motor
5.40%
-0.90%
-2.28%
42.15B
Consumer Cyclical
Sirius XM Holdings
3.15%
-0.87%
-4.84%
7.63B
Communication Services
Based on the activity of 803,590 active portfolios
Open your Smart Portfolio

BCLI Investor Analysis

BCLI investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
15.4%
of BCLI holders
are under 35
Average Segment Performance
Average P/E Ratio20.53
Beta4.60
Dividend Yield4.09%
BCLI investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
53.8%
of BCLI holders
are between 35–55
Average Segment Performance
Average P/E Ratio15.79
Beta11.42
Dividend Yield3.52%
BCLI investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
30.8%
of BCLI holders
are over 55
Average Segment Performance
Average P/E Ratio13.92
Beta3.72
Dividend Yield3.81%
Overview of age group and performance of BCLI stock investors
See who invests in BCLI according to age group and performance.

FAQ

How many retail Investors hold BCLI?
<0.1% of TipRanks' retail investors hold BCLI in their portfolios.
    What is BCLI Investor Sentiment?
    BCLI’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of BCLI in the last 7 days?
      ▲ 4.0% of TipRanks' retail investors changed their holding of BCLI in the last 7 days.
        What percentage of retail investors changed their holding of BCLI in the last 30 days?
        ▲ 10.9% of TipRanks' retail investors changed their holding of BCLI in the last 30 days.
          What is the average age of retail investors who hold BCLI?
          The average age of BCLI Holders is between 35–55.
            What other stocks have BCLI investors also bought?
            BCLI Investors also bought VKTX, DKNG, NIO, LCID, MARA, BMY, JD, RIOT, F, SIRI.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis